Summary
Latest filing:
Daniel R. Passeri is CHIEF EXECUTIVE OFFICER of Cue Biopharma, Inc. (CUE). 1 SEC Form 4 filing on record, dated 18 December 2024. Most recent open-market trade: bought $31K of CUE on 18 December 2024. Lifetime open-market purchases: $31K.
Recent Transactions
1Every recent SEC Form 4 transaction Daniel R. Passeri has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Daniel R. Passeri files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Shao-Lee Lin - $2.61M of CUE open-market activity in the last 12 months
- Sumita Ray - $266K of CUE open-market activity in the last 12 months
- Michael Vincent Meluzio - $169K of CUE open-market activity in the last 12 months
- Pasha Sarraf - $100K of CUE open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Daniel R. Passeri?
Daniel R. Passeri is a corporate insider, tracked as CHIEF EXECUTIVE OFFICER of Cue Biopharma, Inc. (CUE). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Daniel R. Passeri last file a Form 4?
The only primary Form 4 on record is dated 18 December 2024.
Has Daniel R. Passeri been buying or selling stock?
Recorded transactions: 1 open-market purchase ($31K) and 0 open-market sales across all tracked filings.
Where can I see all of Daniel R. Passeri's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Daniel R. Passeri and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
